Qube Research & Technologies LTD Trans Medics Group, Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TMDX
# of Institutions
358Shares Held
29.6MCall Options Held
399KPut Options Held
154K-
Black Rock Inc. New York, NY2.65MShares$415 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$397 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$233 Million2.41% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$214 Million0.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$180 Million3.04% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $5B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...